BRAF mutation marks out specific subgroups of glioma

BRAF mutation marks out specific subgroups of glioma

Background: Molecular markers including isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion have been incorporated into the World Health Organization (WHO) 2016 classification of diffuse gliomas for integrated diagnostic reporting. The prognostic relevance of BRAF mutation among the newly...

Full description

Bibliographic Details
Main Authors: Aden Ka-Yin Chan, Riki Rui-Qi Zhang, Abudumijiti Aibaidula, Zhi Feng Shi, Hong Chen, Ying Mao, Ho Keung Ng
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Glioma
Subjects:
BRAF mutation
clinical stratification
high-grade glioma
lower-grade glioma
prognostic biomarker
Online Access:http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=5;spage=168;epage=174;aulast=Chan

Internet

http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=5;spage=168;epage=174;aulast=Chan

Similar Items